
Education
M.B.A., Northwestern University
B.S., Wake Forest University
Prior Experience
Lincoln International
SunTrust Robinson Humphrey
C&B Capital Companies
The Allied Group
Matt Veal
Managing Director
Mr. Veal joined Croft & Bender in 2017. Prior to joining Croft & Bender, Mr. Veal was a Vice President in the Mergers & Acquisitions division of Lincoln International where he advised middle market companies on mergers, acquisitions and capital raising activities. From 2007 to 2012, Mr. Veal was an Associate at SunTrust Robinson Humphrey where he focused on debt and equity capital markets transactions and advisory services on behalf of the bank's corporate and investment banking clients.
Mr. Veal has completed numerous transactions across a variety of industries on behalf of privately held companies, sponsor-owned businesses, and public companies.
As a Partner of C&B Capital, the private equity affiliate of Croft & Bender, Mr. Veal also has experience on the principal investing side of the business.
Mr. Veal received an M.B.A., with distinction, from Northwestern University's Kellogg School of Management and a B.S. in Finance from Wake Forest University.
Croft & Bender served as a trusted financial advisor and effectively positioned the Company to maximize interest from potential investors. Their experience, sound advice and hard work were instrumental in helping us achieve a great outcome. This investment will allow InductiveHealth to pursue significant product development initiatives. Having the ability to push our innovation practices even further with Diversis, and to grow our world-class team, will mean that we can provide essential public health surveillance and response solutions to even more areas around the country, and eventually the world.
- Matthew Dollacker, CEO & Co-Founder, InductiveHealth
Education
M.B.A., Northwestern University
B.S., Wake Forest University
Prior Experience
Lincoln International
SunTrust Robinson Humphrey
C&B Capital Companies
The Allied Group
Croft & Bender served as a trusted financial advisor and effectively positioned the Company to maximize interest from potential investors. Their experience, sound advice and hard work were instrumental in helping us achieve a great outcome. This investment will allow InductiveHealth to pursue significant product development initiatives. Having the ability to push our innovation practices even further with Diversis, and to grow our world-class team, will mean that we can provide essential public health surveillance and response solutions to even more areas around the country, and eventually the world.
- Matthew Dollacker, CEO & Co-Founder, InductiveHealth